drugset / Trial / NCT06050915
A Study of DISC-3405 in Healthy Volunteers
RandomizedSequentialDouble-blindTreatment
Summary
This phase 1 study will assess the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of DISC-3405 in adult male and female healthy volunteers.
Timeline
- Start
- 2023-10-03
- Primary completion
- 2024-07-09
- Completion
- 2024-07-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DISC-3405 | Unknown | — | Intravenous |
Indications
No indication recorded.